ClinConnect ClinConnect Logo
Search / Trial NCT02939417

One Year Clinical Evaluation of E.Max Laminate Veneers With and Without Using Grape Seed Extract as a Natural Collagen Cross-linking Agent Before Bonding

Launched by MARWA SALEM · Oct 18, 2016

Trial Information

Current as of May 30, 2025

Unknown status

Keywords

Laminate Veneers Grape Seed Extract Emax Collagen Cross Linking Agent

ClinConnect Summary

Justification for undertaking the trial:

Ceramic veneers have become a popular dental procedure since its introduction because they provide excellent esthetics.1 Achieving the good esthetic results especially with ceramic veneers is probably the most challenging task encountered by dental practitioners and ceramist today. Ceramic veneers are indicated for teeth with moderate discoloration, restoration of traumatized, fractured, worn dentition and abnormal tooth anatomy.2 Many factors affect the long term success of ceramic laminate veneers. The most repeated failure patterns associated wit...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients between 20-40 years old, able to read and sign the informed consent document.
  • 2. Patients having teeth with exposed dentin surface limited to cervical third.
  • 3. Patients, healthy physically and psychologically, able to tolerate conventional restorative procedures.
  • 4. Patients don't have active periodontal or pulpal diseases and have teeth with good restorations.
  • 5. Patients with normal occlusion.
  • 6. Patients with teeth problems indicated for laminate veneer (e.g. discoloration, mild malposition, fracture not involving more than 50% enamel loss, ....)
  • 7. Patients willing to return for follow-up examination and evaluation.
  • Exclusion Criteria:
  • 1. Patients in the growth stage with partially erupted teeth.
  • 2. Patients with fractured teeth with more than 50% enamel loss.
  • 3. Patients with poor oral hygiene and lack of motivation.
  • 4. Pregnant women.
  • 5. Patients with abnormal occlusion (eg. edge to edge, deep bite, ...)
  • 6. Patients with parafunctional habits (eg. Bruxism, biting on hard objects, ...)
  • 7. Patients with endodontically treated teeth.
  • 8. Lack of opposite occluding dentition in the area intended for restoration.
  • 9. Psychiatric problems or unrealistic expectations.

About Marwa Salem

Marwa Salem is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a strong focus on ethical standards and regulatory compliance, Marwa Salem leads the design and implementation of clinical trials across various therapeutic areas. The organization collaborates with leading healthcare professionals and institutions to ensure rigorous methodologies and robust data collection, ultimately contributing to the development of safe and effective treatments. By fostering a culture of transparency and collaboration, Marwa Salem aims to drive scientific discovery and enhance the quality of care in the healthcare landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Heba Hamza, Professor

Study Director

Faculty of Oral and Dental Medicine- Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials